Campbell Newman Asset Management’s Integra LifeSciences IART Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,061
| Closed | -$612K | – | 113 |
|
|
2023
Q4 | $612K | Sell |
14,061
-208
| -1% | -$9.06K | 0.05% | 99 |
|
|
2023
Q3 | $545K | Sell |
14,269
-260
| -2% | -$9.93K | 0.05% | 102 |
|
|
2023
Q2 | $598K | Buy |
14,529
+314
| +2% | +$12.9K | 0.05% | 100 |
|
|
2023
Q1 | $816K | Buy |
14,215
+127
| +0.9% | +$7.29K | 0.08% | 94 |
|
|
2022
Q4 | $790K | Buy |
14,088
+447
| +3% | +$25.1K | 0.08% | 93 |
|
|
2022
Q3 | $578K | Buy |
13,641
+324
| +2% | +$13.7K | 0.07% | 95 |
|
|
2022
Q2 | $720K | Buy |
13,317
+574
| +5% | +$31K | 0.08% | 94 |
|
|
2022
Q1 | $819K | Buy |
12,743
+243
| +2% | +$15.6K | 0.08% | 94 |
|
|
2021
Q4 | $837K | Buy |
12,500
+333
| +3% | +$22.3K | 0.07% | 96 |
|
|
2021
Q3 | $833K | Buy |
12,167
+634
| +5% | +$43.4K | 0.09% | 94 |
|
|
2021
Q2 | $787K | Buy |
11,533
+584
| +5% | +$39.9K | 0.08% | 99 |
|
|
2021
Q1 | $756K | Buy |
10,949
+506
| +5% | +$34.9K | 0.08% | 99 |
|
|
2020
Q4 | $678K | Buy |
10,443
+781
| +8% | +$50.7K | 0.08% | 98 |
|
|
2020
Q3 | $456K | Buy |
9,662
+174
| +2% | +$8.21K | 0.06% | 107 |
|
|
2020
Q2 | $446K | Buy |
9,488
+85
| +0.9% | +$4K | 0.06% | 102 |
|
|
2020
Q1 | $420K | Sell |
9,403
-518
| -5% | -$23.1K | 0.07% | 97 |
|
|
2019
Q4 | $578K | Buy |
9,921
+65
| +0.7% | +$3.79K | 0.08% | 101 |
|
|
2019
Q3 | $592K | Sell |
9,856
-80
| -0.8% | -$4.81K | 0.08% | 98 |
|
|
2019
Q2 | $555K | Buy |
9,936
+658
| +7% | +$36.8K | 0.08% | 103 |
|
|
2019
Q1 | $517K | Buy |
9,278
+218
| +2% | +$12.1K | 0.08% | 103 |
|
|
2018
Q4 | $409K | Buy |
9,060
+944
| +12% | +$42.6K | 0.07% | 107 |
|
|
2018
Q3 | $535K | Buy |
8,116
+421
| +5% | +$27.8K | 0.08% | 105 |
|
|
2018
Q2 | $496K | Buy |
7,695
+354
| +5% | +$22.8K | 0.08% | 102 |
|
|
2018
Q1 | $406K | Buy |
7,341
+377
| +5% | +$20.9K | 0.07% | 108 |
|
|
2017
Q4 | $333K | Buy |
6,964
+1,234
| +22% | +$59K | 0.06% | 112 |
|
|
2017
Q3 | $289K | Buy |
5,730
+739
| +15% | +$37.3K | 0.05% | 111 |
|
|
2017
Q2 | $272K | Buy |
+4,991
| New | +$272K | 0.05% | 108 |
|